Arthur T. Sands
2007 - Lexicon Pharmaceuticals
In 2007, Arthur T. Sands earned a total compensation of $1.8M as President, Chief Executive Officer and Director at Lexicon Pharmaceuticals, a 7% decrease compared to previous year.
Compensation breakdown
| Bonus | $265,000 |
|---|---|
| Option Awards | $999,532 |
| Salary | $522,875 |
| Other | $6,339 |
| Total | $1,793,746 |
Sands received $999.5K in option awards, accounting for 56% of the total pay in 2007.
Sands also received $265K in bonus, $522.9K in salary and $6.3K in other compensation.
Rankings
In 2007, Arthur T. Sands' compensation ranked 2,574th out of 8,700 executives tracked by ExecPay. In other words, Sands earned more than 70.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,574 out of 8,700 | 70th |
Division Manufacturing | 882 out of 3,314 | 73rd |
Major group Chemicals And Allied Products | 165 out of 746 | 78th |
Industry group Drugs | 89 out of 546 | 84th |
Industry Pharmaceutical Preparations | 69 out of 364 | 81st |
Source: SEC filing on March 19, 2010.
Sands' colleagues
We found four more compensation records of executives who worked with Arthur T. Sands at Lexicon Pharmaceuticals in 2007.
News
Nurix Therapeutics CEO Arthur Sands' 2023 pay falls 54% to $4.4M
March 27, 2024
Nurix Therapeutics CEO Arthur Sands' 2022 pay jumps 97% to $9.4M
March 24, 2023
Nurix Therapeutics COO Stefani Wolff receives $7.1M in 2021
March 25, 2022
Nurix Therapeutics CEO Arthur Sands' 2020 pay jumps 1,041% to $17M
March 25, 2021